Evidence map›Paper›PMID 38727829›Full record

Trial reportEuropean journal of nuclear medicine and molecular imaging2024

Diagnostic efficacy of [

Hui Yuan, Entao Liu, Guojin Zhang, Chaoquan Lai, Qing Zhang, Yuxiang Shang, Zhen Cheng, Lei Jiang

Registry-linked trialAbstract readComparative StudyClinical Trial
PubMed Publisher
In one paragraph

Trial report in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07342231 (FAP-1 Study), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07342231 recruitingnot on this mapstarted 2025, after this paper: background citation

FAP-1 Study: FAPi PET in Pancreatic Ductal Adenocarcinoma: A Prospective, Exploratory Study

TypeobservationalSponsorTata Memorial HospitalRan2025 to 2027Enrolled60ConditionsPancreatic Cancer, Adenocarcinoma PancreasArmsGa-68 FAPi PET/CT
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Head-to-head comparison ofEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hui Yuan *PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, China.
Entao Liu *PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, China.
Guojin Zhang *PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, China.
Chaoquan LaiInstitute of Molecular Medicine, College of Life and Health Sciences, Northeastern University, Shenyang, China.
Qing ZhangPET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, China.
Yuxiang ShangPET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, China.
Zhen ChengState Key Laboratory of Drug Research, Molecular Imaging Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. zcheng@simm.ac.cn.
Lei JiangPET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, China. leijiang1031@163.com.ORCID 0000-0002-9479-132X

Funding

Gansu Science and Technology Major Project 23ZDFA014Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application 2022B1212010011Guangdong Provincial People's Hospital KY0120211130National Natural Science Foundation of China 81971645National Natural Science Foundation of China U2267221Shandong Laboratory Program SYS202205Shanghai Municipal Science and Technology Major Project TM202301H003
6 · The paper itself

Abstract

purposeTo identify the biodistribution and diagnostic performance of a novel fibroblast activation protein (FAP) targeted positron emission tomography (PET) tracer, [

methodsTwenty-six patients histologically proven with cancers of nasopharyngeal (n = 5), esophagus (n = 5), gastro-esophagus (n = 1), stomach (n = 7), liver (n = 3), and colorectum (n = 5) were recruited for [

resultsSignificant glandular uptake of [

conclusionDespite prominent glandular uptake, [

Indexed as

Fluorodeoxyglucose F18NeoplasmsPositron Emission Tomography Computed TomographyAdultAgedFemaleHumansMaleMiddle AgedProspective StudiesRadiopharmaceuticalsTissue DistributionFluorodeoxyglucose F18Radiopharmaceuticals[68Ga]GaFAPIGly-pro sequencePET

Identifiers

PMID38727829

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.